Position
PRUDENTIAL PLC in Regeneron Pharmaceuticals, Inc.
Back to the book · All holders of REGN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $1.47K$771.87 → $772.64
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.92K | $1.48M | — | — | — | 0.0% |
| Q1 2026 | 3.99K | $3.08M | $772.64 | $1.47K | $1.6M | 0.0% |